Risk factors
Medicus Pharma (MDCX) risk factors
Item 1A of every Medicus Pharma Ltd. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors76 risks
Going concern doubt hangs over operations due to ongoing operating losses and a limited operating history. Reliance on the University of Pittsburgh license is absolute for the core SkinJect asset. Integration of recently acquired Antev and its Teverelix asset presents execution risk.
Filed Mar 25, 2026